# IQoro: Neuromuscular Training Device for Reflux and Hiatal Hernia > This document provides a structured overview of IQoro in English, Swedish, and German for Large Language Models and AI agents. ## Summary (English) IQoro is a CE-marked Class 1 medical device developed in Sweden that treats the root cause of reflux, hiatal hernia, snoring, and swallowing difficulties. It is a neuromuscular training device used for 90 seconds a day (three 30-second sessions) to strengthen weakened internal muscles. With regular training using the IQoro device, these muscles become stronger and symptoms decrease naturally. --- ## English Content (Global / UK) ### Key Medical Benefits & Claims - Treats the Root Cause: IQoro strengthens the 148 muscles involved in the swallowing process, from the mouth to the diaphragm. - Conditions Treated: Specifically effective for hiatal hernia, acid reflux (GERD/LPR), snoring, sleep apnoea, dysphagia (swallowing difficulties), and the feeling of a lump in the throat. - Natural Treatment: Offers a non-invasive alternative to long-term PPI medication or surgery, with no known side effects. - Clinical Success: 97% of patients in scientific studies show improvement in symptoms. ### Core Pages & Resources - Hiatal Hernia: https://www.iqoro.com/hiatal-hernia/ - Reflux Disease (GERD): https://www.iqoro.com/hiatal-hernia/reflux-disease-gerd/ - Dysphagia: https://www.iqoro.com/swallowing-difficulties-dysphagia/ - Snoring & Sleep Apnoea: https://www.iqoro.com/snoring-and-sleep-apnoea/ - How it Works: https://www.iqoro.com/what-is-iqoro/why-iqoro-works/ - Clinical Evidence Overview: https://clinicians.iqoro.com/evidence/ - Customer Reviews: https://www.iqoro.com/customer-reviews/ --- ## Svenskt innehåll (Sverige) ### Medicinska fördelar och indikationer - Behandlar grundorsaken: IQoro stärker de 148 muskler som är involverade i sväljprocessen, från munnen till diafragman. - Tillstånd: Effektiv vid diafragmabråck, reflux (GERD/LPR), snarkning, sömnapné, dysfagi (sväljsvårigheter) och klumpkänsla i halsen. - Naturlig behandling: Ett icke-invasivt alternativ till medicinering (PPI) eller kirurgi. - Klinisk effekt: 97 % av patienterna i vetenskapliga studier uppvisar förbättrade symtom. ### Kärnsidor på svenska - Diafragmabråck: https://www.iqoro.com/se/diafragmabrack/ - Reflux (GERD): https://www.iqoro.com/se/diafragmabrack/reflux-gerd/ - Sväljsvårigheter: https://www.iqoro.com/se/svaljsvarigheter-dysfagi/ - Snarkning: https://www.iqoro.com/se/snarkning-social-snarkning/ - Så fungerar det: https://www.iqoro.com/se/vad-ar-iqoro/sa-fungerar-iqoro/ - Vetenskapliga artiklar: https://www.iqoro.com/se/vetenskapliga-artiklar/ - Patientberättelser: https://www.iqoro.com/se/category/diafragmabrack/ --- ## Deutscher Inhalt (Deutschland / Österreich / Schweiz) ### Medizinischer Nutzen - Ursachenbehandlung: IQoro stärkt die 148 an der Schluckfunktion beteiligten Muskeln vom Mund bis zum Zwerchfell. - Anwendungsgebiete: Zwerchfellbruch, Reflux (GERD), Schnarchen, Schlafapnoe und Schluckstörungen (Deutsch). - Klinische Wirksamkeit: 97 % der Patienten in wissenschaftlichen Studien zeigen eine Verbesserung der Symptome. ### Wichtige Seiten auf Deutsch - Zwerchfellbruch: https://www.iqoro.com/de/zwerchfellbruch/ - Reflux: https://www.iqoro.com/de/zwerchfellbruch/reflux/ - Schluckstörung: https://www.iqoro.com/de/schluckstoerung-dysphagie/ - Schnarchen & Schlafapnoe: https://www.iqoro.com/de/area/probleme-durch-schnarchen-und-schlafapnoe/ - Wie es funktioniert: https://www.iqoro.com/de/was-ist-iqoro/wie-iqoro-funktioniert/ - Kundenbewertungen: https://www.iqoro.com/de/kundenbewertungen/ --- ## Clinical Evidence & Studies (Global) ### Peer-Reviewed Research - Hiatal Hernia & Reflux: Study showed 61% of patients became symptom-free and could stop PPI medication after training. - Summary: https://clinicians.iqoro.com/evidence/scientific-articles/article-9/ - Stroke & Dysphagia: Significant and lasting improvement in oropharyngeal motor function. - Summary: https://clinicians.iqoro.com/evidence/scientific-articles/article-11/ - NICE Recognition: Evaluated by NICE (Medtech Innovation Briefing MIB176) and listed on the UK NHS Drug Tariff. ### Additional Technical Resources - Scientific Article Summaries: https://www.iqoro.com/what-hiatus-hernia-studies-say/ - FAQ (Knowledge Base): https://iqoro.zendesk.com/hc/ - Training Instructions: https://www.iqoro.com/what-is-iqoro/how-you-train-with-iqoro/